会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 64. 发明授权
    • 2-Amino-6-dialkylaminodihydropyridines, their production, pharmaceutical
compositions and methods of use thereof
    • 2-氨基-6-二烷基氨基二氢吡啶,它们的制备,药物组合物及其使用方法
    • US4004014A
    • 1977-01-18
    • US545202
    • 1975-01-29
    • Horst MeyerFriedrich BossertWulf VaterKurt Stoepel
    • Horst MeyerFriedrich BossertWulf VaterKurt Stoepel
    • A61K31/4427A61K31/455A61P1/00A61P3/06A61P9/06A61P9/08A61P9/10A61P9/12A61P11/00A61P15/04C07D211/90C07D401/04C07D211/00C07D401/00
    • C07D211/90
    • 2-Amino-6-dialkylaminodihydropyridines exist in tautomeric form and are represented by the formulae ##STR1## WHEREIN R.sub.1 and R.sub.3 are the same or different and each is straight, branched or cyclic alkyl, alkenyl or alkynyl or said alkyl, alkenyl or alkynyl interrupted by 1 or 2 oxygen atoms;R.sub.2 is a saturated, partially unsaturated or unsaturated straight, branched or cyclic hydrocarbon; aryl unsubstituted or substituted by 1, 2 or 3 of the same or different substituents selected from the group consisting of alkyl, alkoxy, azido, halo, cyano, nitro, trifluoromethyl, carbalkoxy and SO.sub.n -alkyl wherein n is 0, 1 or 2; naphthyl; quinolyl; isoquinolyl; pyridyl; pyrimidyl; thenyl; or furyl; andR.sub.4 and R.sub.5 are each lower alkyl; benzyl; or, together with the nitrogen atom to which they are attached, a 4- to 7-membered ring. These compounds are useful for their coronary-vessel-dilating effect, their antihypertensive effect, their anti-fibrillation effect, their vascular-spasmolytic effect and their muscular-spasmolytic effect.
    • 2-氨基-6-二烷基氨基二氢吡啶以互变异构形式存在并由下式表示:其中R 1和R 3相同或不同,并且各自为直链,支链或环状烷基,烯基或炔基或所述 被1或2个氧原子间隔的烷基,烯基或炔基; R2是饱和的,部分不饱和的或不饱和的直链,支链或环状烃; 未取代的或被1,2或3个相同或不同的选自烷基,烷氧基,叠氮基,卤素,氰基,硝基,三氟甲基,烷氧基和其中n为0,1或2的烷基的取代基取代的芳基; 萘基; 喹啉基 异喹啉基 吡啶基 嘧啶基 茶碱 或呋喃基; 且R 4和R 5各自为低级烷基; 苄基; 或者与它们所连接的氮原子一起形成4-至7-元环。 这些化合物可用于其冠状血管扩张作用,其抗高血压作用,其抗纤维化作用,其血管解痉作用及其肌肉 - 解痉作用。
    • 68. 发明授权
    • 2-Amino-4 H-pyrane
    • 2-氨基-4H-吡喃
    • US3981893A
    • 1976-09-21
    • US578465
    • 1975-05-19
    • Horst MeyerFriedrich BossertWulf VaterKurt Stoepel
    • Horst MeyerFriedrich BossertWulf VaterKurt Stoepel
    • A61K31/35C07D309/22C07D409/04
    • C07D309/22A61K31/35C07D409/04
    • 2-Amino-4 H-pyrane derivatives of the formula ##SPC1##WhereinR.sup.1 and R.sup.2 are the same or different and each is hydrogen or straight- or branched-chain alkyl;R.sup.3 is straight- or branched-chain alkyl, phenyl or --COOR' wherein R' is a straight, branched or cyclic saturated or unsaturated aliphatic hydrocarbon;R.sup.4 is straight, branched or cyclic alkyl or alkenyl, aryl unsubstituted or substituted by 1, 2 or 3 of the same or different substituents selected from the group consisting of alkyl, alkoxy, halogen, nitro, cyano, trifluoromethyl, carbalkoxy, and --SO.sub.n alkyl wherein n is 0, 1 or 2, orR.sup.4 is naphthyl, quinolyl, pyridyl, thienyl or furyl unsubstituted or substituted by alkyl, alkoxy or halogen;R.sup.5 is straight, branched or cyclic alkyl or --OR" wherein R" is a straight, branched or cyclic hydrocarbon or said hydrocarbon interrupted by 1 or 2 oxygen atoms; andR.sup.6 is hydrogen or alkyl;Are useful for their strong coronary action and as antihypertensive agents.
    • 式WHEREIN R1和R2的2-氨基-4H-吡喃衍生物相同或不同,各自为氢或直链或支链烷基; R3是直链或支链烷基,苯基或-COOR',其中R'是直链,支链或环状的饱和或不饱和脂族烃; R4是直链,支链或环状的烷基或链烯基,未被取代或被1,2或3个相同或不同的选自烷基,烷氧基,卤素,硝基,氰基,三氟甲基,烷氧羰基和-SOn 烷基,其中n为0,1或2,或R4为萘基,喹啉基,吡啶基,噻吩基或呋喃基,未取代或被烷基,烷氧基或卤素取代; R5是直链,支链或环状烷基或-OR“,其中R”是直链,支链或环状烃或被1或2个氧原子间断的所述烃; R6为氢或烷基; 有用于其强大的冠状动脉和抗精神病药。